Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between BR1010 and Co-administration of BR1010-1 and BR1010-2 in Healthy Volunteers

The purpose of this study is to evaluate the Pharmacokinetics and safety/tolerability between Fimasartan/Amlodipine/Hydrochlorothiazide and co administration of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy volunteers.

Inclusion Criteria:

• A healthy adults aged 19-50 years

Exclusion Criteria:

• History or presence of clinically significant medical or psychiatric condition or disease
• Hypersensitivity to ingredient of IP and other medication, food
• Participation in any other study within 3months
• History of whole blood donation within 2months and Apheresis 1month